Email this article EMERGENCE OF BEDAQUILINE RESISTANCE AFTER COMPLETION OF BEDAQUILINE-BASED DRUGRESISTANT TB TREATMENT: A CASE STUDY FROM SOUTH AFRICA
- Authors: de Vos M.1, Ley S.1, Derendinger B.1, Dippenaar A.1, Grobbelaar M.1, Reuter A.2, Daniels J.2, Burns S.3, Theron G.1, Posey J.3, Warren R.1, Cox H.4
-
Affiliations:
- DST/NRF Centre of Excellence in Biomedical Tuberculosis Research/SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human, Faculty of Medicine and Health Science, Stellenbosch University
- Médecins Sans Frontières, Operational Centre Brussels (OCB), Khayelitsha Project, Cape Town
- Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia
- Institute of Infectious Disease and Molecular Medicine and Division of Medical Microbiology, Department of Pathology, Faculty of Health Sciences, University of Cape Town
- Issue: Vol 8, No 4 (2018)
- Pages: 566
- Section: TUBERCULOSIS AND MYCOBACTERIA: MOLECULAR APPROACH
- Submitted: 10.01.2019
- Accepted: 10.01.2019
- Published: 30.12.2018
- URL: https://iimmun.ru/iimm/article/view/1006
- DOI: https://doi.org/10.15789/2220-7619-2018-4-6.11
- ID: 1006
Cite item
Full Text
Abstract
About the authors
M. de Vos
DST/NRF Centre of Excellence in Biomedical Tuberculosis Research/SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human, Faculty of Medicine and Health Science, Stellenbosch University
Author for correspondence.
Email: fake@neicon.ru
ЮАР
S. Ley
DST/NRF Centre of Excellence in Biomedical Tuberculosis Research/SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human, Faculty of Medicine and Health Science, Stellenbosch University
Email: fake@neicon.ru
ЮАР
B. Derendinger
DST/NRF Centre of Excellence in Biomedical Tuberculosis Research/SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human, Faculty of Medicine and Health Science, Stellenbosch University
Email: fake@neicon.ru
ЮАР
A. Dippenaar
DST/NRF Centre of Excellence in Biomedical Tuberculosis Research/SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human, Faculty of Medicine and Health Science, Stellenbosch University
Email: fake@neicon.ru
ЮАР
M. Grobbelaar
DST/NRF Centre of Excellence in Biomedical Tuberculosis Research/SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human, Faculty of Medicine and Health Science, Stellenbosch University
Email: fake@neicon.ru
ЮАР
A. Reuter
Médecins Sans Frontières, Operational Centre Brussels (OCB), Khayelitsha Project, Cape Town
Email: fake@neicon.ru
ЮАР
J. Daniels
Médecins Sans Frontières, Operational Centre Brussels (OCB), Khayelitsha Project, Cape Town
Email: fake@neicon.ru
ЮАР
S. Burns
Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia
Email: fake@neicon.ru
США
G. Theron
DST/NRF Centre of Excellence in Biomedical Tuberculosis Research/SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human, Faculty of Medicine and Health Science, Stellenbosch University
Email: fake@neicon.ru
ЮАР
J. Posey
Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia
Email: fake@neicon.ru
США
R. Warren
DST/NRF Centre of Excellence in Biomedical Tuberculosis Research/SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human, Faculty of Medicine and Health Science, Stellenbosch University
Email: fake@neicon.ru
ЮАР
H. Cox
Institute of Infectious Disease and Molecular Medicine and Division of Medical Microbiology, Department of Pathology, Faculty of Health Sciences, University of Cape Town
Email: fake@neicon.ru
ЮАР
Supplementary files
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).